Assignee
ADT PHARMACEUTICALS LLC
US·10 granted patents·36 citations·filing 2015–2022
Top patents by PatentIndex Score
10 records- 0196US10981886B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS LLC·Filed 2019·Granted Apr 20, 2021·5 cites·15 claims
- 0296US10975054B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS LLC·Filed 2019·Granted Apr 13, 2021·5 cites·17 claims
- 0395US11198679B2Method of treating or preventing Ras-mediated diseasesADT PHARMACEUTICALS LLC·Filed 2020·Granted Dec 14, 2021·3 cites·6 claims
- 0495US11130744B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS LLC·Filed 2020·Granted Sep 28, 2021·3 cites·15 claims
- 0594US10526307B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS LLC·Filed 2015·Granted Jan 7, 2020·11 cites·15 claims
- 0691US11407727B2Indenyl compounds, pharmaceutical compositions, and medical uses thereofADT PHARMACEUTICALS LLC·Filed 2020·Granted Aug 9, 2022·2 cites·6 claims
- 0790US11104658B2Method of treating or preventing Ras-mediated diseasesADT PHARMACEUTICALS LLC·Filed 2015·Granted Aug 31, 2021·3 cites·8 claims
- 0889US11680073B2Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and usesADT PHARMACEUTICALS LLC·Filed 2021·Granted Jun 20, 2023·1 cites·16 claims
- 0989US11186596B2Anticancer indenes, indanes, azaindenes, azaindanes, pharmaceutical compositions and usesADT PHARMACEUTICALS LLC·Filed 2019·Granted Nov 30, 2021·3 cites·20 claims
- 1082US12479813B2Method of therapeutically treating cancerADT PHARMACEUTICALS LLC·Filed 2022·Granted Nov 25, 2025·0 cites·1 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →